Article
Adjuvantation of whole-killed Leishmania vaccine with anti-CD200 and anti-CD300a antibodies potentiates its efficacy and provides strong protection against virulent parasites
2022-07-26
Abstract excerpt
<title>Abstract</title> <p>The poor abilities of parasitic antigens to induce cell-mediated immunity is one of the major reasons for the limited success of vaccine candidates against all forms of leishmaniasis. Here we find, for the first time, that the adjuvantation of whole-killed Leishmania vaccine with anti-CD200 and anti-CD300a antibodies significantly enhances CD4+ T cells mediated immunity in vaccinated an...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- e6d7c9bc-15dd-5cc0-81b5-cf9b9be789d4
- DOI
- 10.21203/rs.3.rs-1817941/v1
